Ixr1, a Yeast Protein That Binds to Platinated DNA and Confers Sensitivity to Cisplatin
- 30 July 1993
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 261 (5121) , 603-605
- https://doi.org/10.1126/science.8342024
Abstract
Structure-specific recognition proteins (SSRPs) bind to DNA containing intrastrand cross-links formed by the anticancer drug cisplatin. A yeast gene encoding an SSRP, designated IXR1, was cloned and sequenced. The Ixr1 protein, a member of the high mobility group-box protein family, bound specifically to DNA modified with cisplatin but not inactive platinum compounds. A yeast strain with an inactivated IXR1 gene was half as sensitive to cisplatin and accumulated one-third as many platinum-DNA lesions after treatment with cisplatin as the parental strain. These findings suggest that SSRPs play a role in mediating the cytotoxicity of cisplatin.Keywords
This publication has 22 references indexed in Scilit:
- Excision repair of DNA in nuclear extracts from the yeast Saccharomyces cerevisiaeBiochemistry, 1992
- DNA-binding properties of the HMG domain of the lymphoid-specific transcriptional regulator LEF-1.Genes & Development, 1991
- Overview of manual and automated DNA sequencing by the dideoxy chain termination methodMethods, 1991
- Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatinBiochemistry, 1990
- Nucleolar transcription factor hUBF contains a DNA-binding motif with homology to HMG proteinsNature, 1990
- Biological Processing of DNA Modified by Platinum CompoundsPublished by Wiley ,1990
- Synergistic activation by the glutamine-rich domains of human transcription factor Sp1Cell, 1989
- Resistance to platinum compounds: Mechanisms and beyondEuropean Journal of Cancer and Clinical Oncology, 1989
- The yeast secretory pathway is perturbed by mutations in PMR1, a member of a Ca2+ ATPase familyCell, 1989
- Structural aspects of platinum anticancer drug interactions with DNAChemical Reviews, 1987